The global demand for Compounding Pharmacies Market is presumed to reach the market size of nearly USD 22.19 Billion by 2032 from USD 12.59 Billion in 2023 with a CAGR of 6.5% under the study period 2024 - 2032.
Compounding pharmacies are a safe and reliable way to receive customized medications. Compounding pharmacies are specific types of pharmacies. Compounding pharmacies are to make drugs prescribed by doctors for specific patients with needs that commercially available drugs cannot meet. Compounding pharmacies can create customized dosage forms based on patient preferences and restrictions. Compounding pharmacies will only issue those medications obtained via a doctor's prescription. Compounding pharmacies undergo an extra quality assessment to assure consumers that the product has been compounded to compounding standards.
The chronic diseases such as cancer are becoming more common along with increasing funding for compounding pharmacies will boost the market over the forecast period. Also, the shortage of drugs is a strong reason for the growth of compounding pharmacies across the region. Moreover, the growing awareness about the benefits of compounded medications will lead to higher use of such personalized medications and result in market growth. The surging investments by the key market players in research and development to innovate and customize the formulations to effectively treat various diseases are expected to boost the growth of the compounding pharmacies market. However, increased restrictions on manufacturing complex formulations may hinder the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of compounding pharmacies. The growth and trends of compounding pharmacies industry provide a holistic approach to this study.
This section of the compounding pharmacies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Therapeutic Area
By Product
By Application
By Compounding Type
By Sterility
By Distribution Channel
This section covers the regional outlook, which accentuates current and future demand for the Compounding Pharmacies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the compounding pharmacies market include Fagron, B. Braun, Nephron Pharmaceuticals Corporation, Fresenius Kabi, Athenex Pharma Solutions (Athenex Inc.), Dougherty's Pharmacy, Inc., Clinigen Group PLC, Pencol Compounding Pharmacy, Lorraine's Pharmacy, McGuff Company Inc. (McGuff Compounding Pharmacy Services), Institutional Pharmacy Solutions, Rx3 Compounding Pharmacy, Wedgewood Village Pharmacy, Inc. and Triangle Compounding Pharmacies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . COMPOUNDING PHARMACIES – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Therapeutic Area
3.7.2 Market Attractiveness Analysis By Product
3.7.3 Market Attractiveness Analysis By Application
3.7.4 Market Attractiveness Analysis By Compounding Type
3.7.5 Market Attractiveness Analysis By Sterility
3.7.6 Market Attractiveness Analysis By Distribution Channel
3.7.7 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY THERAPEUTIC AREA
5.1 Overview by Therapeutic Area
5.2 Historical and Forecast Data
5.3 Analysis by Therapeutic Area
5.4 Dermatology Historic and Forecast Sales by Regions
5.5 Pain Management Historic and Forecast Sales by Regions
5.6 Specialty Drugs Historic and Forecast Sales by Regions
5.7 Nutritional Supplements Historic and Forecast Sales by Regions
5.8 Hormone Replacement Historic and Forecast Sales by Regions
5.9 Others Historic an...
